MedPath

Effect of Hyoscine-N-Butyl Bromide on Hysterosalpingography-Associated Pain and Tubal Spasm. A Double-Blind Randomized Placebo-Controlled Study

Not Applicable
Recruiting
Conditions
Fertility-female
Registration Number
PACTR202407618349397
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
136
Inclusion Criteria

All adult patients (female) = 18 years undergoing hysterosalpingography at the study centre during the study period and do not have any of the exclusion criteria

Exclusion Criteria

Non-consenting patients.
Patients with active pelvic inflammatory disease
Patients with a history of any allergy to radiopaque dye
Patients with previous cervical surgery.
Patients who took any form of analgesic within 6-hours before the procedure.
Patients with congenital uterine abnormality or other indications for HSG aside from infertility.
Patients with cardiac disease, e.g. cardiac failure, cardiac arrhythmias, hypertensive heart disease
Patients with known allergies to hyoscine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain score;Tubal spasm
Secondary Outcome Measures
NameTimeMethod
Incidence of side effects of hyoscine butyl bromide when used during HSG
© Copyright 2025. All Rights Reserved by MedPath